INDAPAMIDE WATSON indapamide hemihydrate 2.5mg sugar coated tablet bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

indapamide hemihydrate, Quantity: 2.5 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

indapamide hemihydrate

Pharmaceutical form:

Tablet, sugar coated

Composition:

Excipient Ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; Acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; Shellac; white beeswax; Carnauba Wax

Administration route:

Oral

Units in package:

60 tablets, 90 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Management of essential hypertension. It may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. Normally indapamide is used as the initial agent in multiple drug regimens.

Product summary:

Visual Identification: White, biconvex, sugar coated tablets.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-04-05